Company Directory - Pharmaco

Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We focus on improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

Astex is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the central nervous system (CNS). We are a member of one of Japan’s leading pharmaceutical companies, the Otsuka group, and therefore benefit from the resources and commitment of a global pharmaceutical company.

AstraZeneca is one of the world’s most exciting bio-pharmaceutical companies. From scientists to sales, lab techs to legal we’re on a mission to turn ideas into life-changing medicines that improve patients’ lives and benefit society.

Atlas is a state-of-the-art 503B facility built with ISO 5 class hoods, ISO 7 class clean rooms and 24/7 environmental monitoring with high efficiency particulate air quality. We leverage 17 years of compounding expertise and quality processing to deliver the highest level of patient care and patient safety possible for each and every product we deliver.

We are a biopharmaceutical company specifically pioneering the development of host-targeting antiviral therapies set up by a team of leading scientists in viral research and seasoned industry experts. The Company aims to develop new antiviral therapies against different severe respiratory viral infections with a high unmet medical need.

Aucta Pharmaceuticals, Inc. (AUCTA, Latin-improved, enhanced) is a technology based company focusing on the development and commercialization of Branded Specialty Products. Aucta is a pharmaceutical company creating better products of proven molecules using 505(b)(2) regulatory pathway.

Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.

We are a biopharmaceutical company passionately committed to providing solutions for overlooked and unmet medical needs through patient-focused, innovative products. We are thoughtful in our approach to identifying patient needs and finding better ways to serve them.

Every day, we bring a singular focus to the research and development of groundbreaking pharmaceutical treatments for people with central nervous system (CNS) conditions.

Avion Pharmaceuticals is focused on providing innovative products for women and dermatology patients across a continuum of care. We have a commitment to quality and are determined to deliver the right products to improve patient lives and well being.

Aytu is committed to improving the health of all children. We’re developing a portfolio of products to help children be their best by addressing significant conditions that affect children and their families every day. Our adult and consumer health products remain an important part of our heritage, while we study potential COVID-19 treatments and are now investing in potential breakthroughs for rare diseases.

Azurity’s mission is to make safe, high-quality treatments for patients who require formulations of drugs other than what is commonly commercially available. We focus on the needs of special patient populations, such as children and the elderly, for whom customized doses and user-friendly formulations tailored to their needs do not exist.

Over 70 years ago, B.F. Ascher & Company, Inc. began providing healthcare products for better living. Founder Bordner "Bo" Ascher started his company just outside of Kansas City with a focus on manufacturing prescription pharmaceuticals. By the 1970's, B.F. Ascher & Company decided to offer products directly to the consumer.

Basilea is a revenue-generating, commercial-stage Swiss biopharmaceutical company. Our activities are focused in the areas of oncology, hospital antibiotics and hospital antifungals. Our portfolio comprises of two marketed anti-infective brands (Cresemba® and Zevtera®) and two oncology drug candidates in development.

We are a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals.

We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. We engage with physicians and scientific leaders around the world with the aim to further medical research.

Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date.

We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

CMIC is an innovative and unique provider of high-quality solutions for the healthcare industry. We create value by accelerating the access to therapies that improve patients’ lives.